Usana Health Sciences Inc SEC Filings

USANA Health Sciences (USNA) – Form 4 filing

On 24-Jul-2025, CEO & President Jim Brown converted 2,190 previously granted restricted stock units (code “M”) into an equal number of common shares. To satisfy withholding taxes, 972 of those shares were automatically surrendered to the issuer at $32.09 per share (code “F”). The net effect is an increase of 1,218 directly held shares, bringing Brown’s direct common-stock ownership to 16,934. He also retains 160,878 unvested/derivative RSUs that will convert into common shares as they vest. No open-market purchases or sales occurred; all transactions were internal equity-compensation settlements. The filing does not disclose any broader corporate developments.

USANA Health Sciences (USNA) Form 4 – Director Ding Xia reported routine equity transactions dated 24 Jul 2025.

• Exercise of RSUs (Code M): 1,058 restricted stock units converted 1:1 into common shares, increasing direct holdings.
• Tax‐withholding sale (Code F): 265 shares were surrendered at $32.09 to satisfy withholding obligations.
• Post-transaction ownership: 5,337 common shares held directly and 3,172 unvested RSUs remain outstanding. RSUs vest 25 % on four quarterly dates between 24 Jul 2025 and 23 Apr 2026.

No purchase or sale of shares for investment purposes occurred; the net change (+793 shares) stems from normal equity compensation. No other directors or officers are listed, and there is no indication of material information affecting USNA’s operations or outlook.

USANA Health Sciences (USNA) Form 4: Director John Turman Fleming reported the automatic conversion of 1,058 Restricted Stock Units (RSUs) into an equal number of common shares on 24 Jul 2025 (transaction code M – derivative conversion). No cash price was paid at conversion.

Post-transaction holdings:

• Common stock held directly: 5,258 shares (up from 4,200).
• Unvested RSUs remaining: 3,172 units.

The RSU award vests in four equal tranches of 25% each on 24 Jul 2025, 23 Oct 2025, 22 Jan 2026 and 23 Apr 2026. Fleming’s filing reflects the first vesting event. There was no open-market buying or selling; the transaction simply moves shares from derivative to common ownership, marginally increasing the director’s freely tradable stake.

Given the modest size relative to USNA’s ~19 million outstanding shares, the event is immaterial to corporate finances. It does, however, signal continued equity alignment between the director and shareholders.

USANA Health Sciences (USNA) – Form 4 filing: Director Gilbert A. Fuller reported the first vesting tranche of a previously granted restricted-stock-unit (RSU) award.

• Transaction date: 24 Jul 2025
• Type (Code M): automatic conversion of RSUs into common shares
• Shares acquired: 1,058 common shares at $0 cost
• Post-transaction ownership: 1,058 common shares held directly and 3,172 RSUs still outstanding
• Vesting schedule of remaining RSUs: 25 % on 23 Oct 2025, 22 Jan 2026, and 23 Apr 2026

The filing reflects routine equity-based compensation; no shares were sold and no cash proceeds were involved. The transaction is unlikely to materially affect the company’s share float or signal a directional view beyond normal incentive alignment.

USANA Health Sciences (USNA) – Form 4 insider filing: Director Peggie Pelosi reported RSU vesting and related share withholding on 24 Jul 2025. She converted 1,058 restricted stock units (code “M”), adding the same number of common shares at a $0 exercise price. To cover taxes, 606 shares were withheld/sold (code “F”) at $32.09, leaving a net increase of 452 shares.

Following the transactions, Pelosi now directly owns 4,135 common shares and still holds 3,172 un-vested/vested RSUs. No open-market purchases or discretionary sales were disclosed; the activity reflects scheduled equity compensation vesting. No changes to company guidance, operations, or financial metrics were included.

On 07/24/2025, USANA Health Sciences (USNA) director Frederic J. Winssinger filed a Form 4 showing the conversion of 1,058 restricted stock units (transaction code “M”) into the same number of common shares. The move increased his directly held common stock to 6,929 shares, up from 5,871, an 18% rise. No shares were sold.

Winssinger still owns 3,172 RSUs that vest in four equal 25 % tranches on 24 Jul 2025, 23 Oct 2025, 22 Jan 2026 and 23 Apr 2026. The filing lists a zero exercise price, typical for RSU settlement, and contains no additional corporate events or financial data. While modest, an insider increasing holdings is generally viewed as a constructive signal rather than a liquidity event.

USANA Health Sciences (USNA) – Form 4 filed 07/28/2025. Director Timothy E. Wood reported transactions dated 07/24/2025 involving restricted stock units (RSUs) and common shares.

• RSU exercise (Code M): 1,058 RSUs converted into an equal number of common shares at a stated price of $0.
• Disposition for tax withholding (Code F): 265 shares sold at $32.09 per share.

After the transactions Wood now directly owns 8,235 common shares. He also retains 3,172 unvested RSUs that convert 25 % on 07/24/2025, 10/23/2025, 01/22/2026, and 04/23/2026.

The filing reflects a net increase of 793 shares in Wood’s direct equity position and provides updated ownership data but does not contain company-level financial results or forward-looking statements.